Αρχική World News Study Suggests Some Arthritis Drugs May Actually Stop the Spread of Breast...

Study Suggests Some Arthritis Drugs May Actually Stop the Spread of Breast Cancer to the Bones

Breast cancer is incapable of killing a person if it stays localized to the breast. However, if left unchecked for too long, it can grow and metastasize to other areas of the body, such as the lungs, brain, liver, or bones, where it is much more dangerous and less treatable. Finding new ways to halt metastasis, therefore, is a top priority for many cancer researchers.Now a group of research teams from the University of Manchester and the University of Sheffield have discovered that the arthritis drugs anakinra, canakinumab, and sulfasalazine may be capable of preventing metastasis to the bones. The researchers found out that a protein called interleukin 1-beta produced by the bone marrow is responsible for encouraging breast cancer to form secondary tumors in the bones, and these arthritis medications block that protein.Photo: Adobe Stock/ThamKC
To test their hypothesis, researchers grew breast cancer cells in liquid that had previously contained bone marrow cells. The cancer cells in that liquid grew much faster than breast cancer cells that were not placed in an environment contaminated by bone marrow cells.Tests were then conducted in mice which revealed that the interleukin 1-beta protein could be effectively blocked by some of the same drugs commonly used to treat arthritis, a condition that causes pain in the joints. When mice with breast cancer were treated with the drug anakinra, for example, only 14 percent of them went on to develop metastatic tumors in their bones. In a control group, 42 percent of the animals developed metastatic tumors in the bone.Photo: Adobe Stock/Joel bubble ben
Researchers hope that their work will soon lead to trials of arthritis drugs on people with breast cancer to see if it is really capable of preventing breast metastasis in humans. More research is needed, however, to find out how anakinra and other arthritis drugs will interact with common cancer drugs and affect patients’ immune systems, which are often compromised by cancer therapies.“We will now look to see if similar processes are also involved in breast cancer growing in other organs, such as the liver and lungs,” says lead study author Dr. Rachel Eyre, from the University of Manchester. “We hope that by continuing this work, we could in future identify those at high risk of their breast cancer spreading, and where possible use drugs already available to prevent this from happening.”
Photo: Adobe Stock/RFBSIPThe new research sheds some light on the possibility of using preexisting drugs to treat breast cancer, and researchers hope to explore other drug types that could help with this purpose.Baroness Delyth Morgan, chief executive of Breast Cancer Now, says, “While more research is needed, it’s really exciting that these well-tolerated and widely-available arthritis drugs may help prevent secondary breast cancer in the bone.”
Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

Καρκίνος και Κορωνοϊός (COVID-19) ΜΕΡΟΣ Α

Εάν είστε καρκινοπαθής, το ανοσοποιητικό σας σύστημα μπορεί να μην είναι τόσο ισχυρό όσο κανονικά, έτσι μπορεί να ανησυχείτε για τους κινδύνους που σχετίζονται...

ΠΑΓΚΟΣΜΙΑ ΗΜΕΡΑ ΚΑΡΚΙΝΟΥ

Η Παγκόσμια Ημέρα Κατά του Καρκίνου καθιερώθηκε με πρωτοβουλία της Διεθνούς Ένωσης κατά του Καρκίνου (UICC), που εκπροσωπεί 800 οργανώσεις σε 155 χώρες του...

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Pembrolizumab Combination for the First-Line Treatment of Cervical Cancer

On 13 October 2021, the US Food and Drug Administration (FDA) approved pembrolizumab (Keytruda, Merck) in combination with chemotherapy, with or without bevacizumab, for...

From Scan to Scan: The Challenges of Living with Metastatic Cancer

October 15, 2021, by NCI Staff Bethany Ross has been living with metastatic neuroendocrine cancer since she was diagnosed in 2018. Credit: Used with permission from...

The award-winning researcher behind next generation sequencing

Next generation sequencing (NGS) has given the genomic research community ultra-high throughput, scalability, and speed that could only be dreamed of 20 years ago....

Many Breast Cancer Patients Use Cannabis to Manage Symptoms But Don’t Tell Their Doctors

Cancer and cancer treatment come with many side effects, including nausea, vomiting, and pain. In addition to the physical toll, the impacts to a...

Medicare Open Enrollment Starts Tomorrow!

Medicare open enrollment is upon us for 2022. If you are a Medicare recipient, this is the time of year when you can make...

Cancer in My Community: Providing Supportive Care in Serbia

Cancer in My Community is a Cancer.Net Blog series that shows the global impact of cancer and how people work to care for those with...